Introduction: The fibrinolysis status can change remarkably in critical care patients. It is beneficial to simultaneously investigate both the fibrinolysis and coagulation status in these patients. Recently, clot-fibrinolysis waveform analysis (CFWA), which is a coagulation and fibrinolysis global assay based on assessing the activated partial thromboplastin time with tissue-type plasminogen activator, was developed. We aimed to investigate the characteristics of CFWA using plasma samples from patients in the critical care unit.
Materials and Methods: The fibrinolysis times using CFWA were measured in a total of 298 plasma samples. These samples were divided into three groups based on the reference interval (RI) of fibrinolysis time using CFWA: shortened group, less than RI; within group, within RI; prolonged group, more than RI. The coagulation and fibrinolysis markers, including D-dimer, plasmin-2 plasmin inhibitor complex (PIC), fibrin monomer complex (FMC), plasmin-2 plasmin inhibitor (2-PI), plasminogen (Plg), and fibrinogen (Fbg) were analyzed and compared among the three groups.
Results: Fbg, Plg, and 2-PI levels in the shortened group were significantly lower than those in the prolonged group. Conversely, the FMC level decreased significantly as the fibrinolysis time increased. The mean values of the fibrinolysis markers D-dimer and PIC in all three groups were higher than the cut-off values, and the PIC value differed significantly between the within and prolonged groups.
Conclusions: The fibrinolysis reaction was detected in all three groups, but the status was different among them. CFWA has the potential to reflect the fibrinolysis status in one global assay.